Effect of intravenous magnesium sulfate versus placebo on postoperative pain and urethral catheter discomforts in patients undergo transurethral ureterolithotripsy
Phase 2
- Conditions
- kidney stone.Calculus of kidney
- Registration Number
- IRCT201410229014N45
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
(a) candidate for transurethral ureterolithotripsy; (b) age of 18 to 70 years; (b) serum magnesium less than 2.5 mg/dl.
Exclusion criteria: (a) transurethral ureterolithotripsy in combination with other procedure; (b) incomplete discharge of stone; (c) general anesthesia; (d) having renal disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of back pain. Timepoint: 6, 12, and 18 hours after surgery. Method of measurement: using Numerical Rating Scale.;Severity of flank pain. Timepoint: 6, 12, and 18 hours after surgery. Method of measurement: using Numerical Rating Scale.;Severity of abdominal pain. Timepoint: 6, 12, and 18 hours after surgery. Method of measurement: using Numerical Rating Scale.;Severity of urethral discomforts. Timepoint: 6, 12, and 18 hours after surgery. Method of measurement: using Numerical Rating Scale.
- Secondary Outcome Measures
Name Time Method umber of analgesic used. Timepoint: during 24 hours after surgery. Method of measurement: Medical record.